Assignment 01

ASSIGNMENT OF MARKETING
Title: Portfolio of GSK

Submitted to: Ma’am Sidra Yaseen
Submitted By: Group 1
Group Member Name
Muhammad Kazim 70098907

Muhammad Hasham 70094784
Abdullah Tariq 70094397
Muhammad Usama 70095030

Umer Draz 70099240
PORTFOLIO OF GSK
Vision
To be a leader in global healthcare, providing innovative medicines, vaccines, and consumer

healthcare products to improve the quality of human life for generations to come.
Mission
Our mission is to help people do more, feel better, and live longer by researching, developing,
manufacturing, and distributing high-quality pharmaceutical and healthcare products. We aim to
achieve this through a commitment to innovation, integrity, and collaboration with healthcare
professionals, patients, and communities worldwide.
Objectives
 Develop Breakthrough Medicines and Vaccines: Continuously innovate to address
unmet medical needs and improve patient outcomes.
 Ensure Access to Products: Work to ensure that our products are accessible to patients
globally, regardless of geographic location or socioeconomic status.
 Maintain Financial Performance: Sustain a strong financial performance to support

ongoing investment in research and development, while delivering value to shareholders.
 Foster Diversity and Inclusion: Create an inclusive workplace culture that celebrates
diversity and fosters a sense of belonging among our employees.
 Promote Sustainability: Minimize our environmental impact through sustainable

practices across our operations and supply chain.
Policies
1. Quality Assurance Policy:
Committed to maintaining the highest standards of quality and safety in all our products
and processes, adhering to regulatory requirements and industry best practices.
2. Compliance Policy:
Operate with integrity, transparency, and ethical conduct, ensuring compliance with all
applicable laws and regulations.
3. Sustainability Policy:
Embed sustainability into our business practices, from sourcing raw materials to product
distribution, to minimize our environmental footprint and contribute positively to society.
4. Diversity and Inclusion Policy:
Promote diversity, equity, and inclusion in our workforce, fostering an environment where
all employees feel valued, respected, and empowered to contribute.
5. Innovation Policy:
Invest in cutting-edge research and development to drive innovation and bring new
therapies and healthcare solutions to market.
Strategies
Short Term:
Focus on optimizing operational efficiency, accelerating the launch of new products, and
enhancing customer engagement to drive revenue growth and market share.
Long Term:
Invest in transformative research and development initiatives, expand into emerging markets with
unmet medical needs, and pursue strategic collaborations and acquisitions to diversify our product
portfolio and sustain long-term growth.
Analysis (ARM/MRM)
Activity Resource Matrix (ARM):
A systematic tool for assessing resource allocation across various activities, helping to identify
inefficiencies and optimize resource utilization.
Market Risk Management (MRM):
Comprehensive analysis of market risks, including regulatory changes, competitive dynamics, and
macroeconomic factors, to inform strategic decision-making and mitigate potential threats to
business performance.
PDCA Cycle (Plan-Do-Check-Act)

1. Plan:
Define objectives, set targets, and develop strategies to achieve desired outcomes.
2. Do:
Implement planned activities, allocate resources, and execute strategies according to
established plans
.
3. Check:
Monitor progress, collect data, and evaluate performance against predefined metrics and
benchmarks.
4. Act:
Analyze findings, identify areas for improvement, and implement corrective actions to
optimize performance and drive continuous improvement.
Crisis Management
 Establishing a dedicated crisis management team with clear roles and responsibilities to
coordinate response efforts during emergencies.
 Developing comprehensive crisis management plans, including communication protocols,
escalation procedures, and contingency strategies to mitigate potential risks and minimize
disruption to operations.
Risk Management
1. Identification:
Regularly assess and identify potential risks across all aspects of the business, including
operational, financial, regulatory, and reputational risks.
2. Mitigation:
Develop proactive risk mitigation strategies and controls to minimize the likelihood and
impact of identified risks, incorporating risk management into decision-making processes
and operational activities.
3. Monitoring:
Continuously monitor and evaluate risk exposure, leveraging data analytics and key risk
indicators to identify emerging risks and adapt mitigation strategies as necessary.
4. Adaptation:
Maintain agility and flexibility in response to evolving risk landscapes, adjusting risk
management strategies and contingency plans to address new threats and opportunities as
they arise.
By implementing these detailed strategies and policies, GSK aims to navigate the complexities of
the healthcare industry effectively, while remaining committed to our mission of improving global
health outcomes and creating long-term value for our stakeholders.

Assignment 01

Uploaded by

Copyright:

Available Formats

Assignment 01

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Assignment 01

Uploaded by

Copyright:

Available Formats

ASSIGNMENT OF MARKETING

Title: Portfolio of GSK

Group Member Name

Muhammad Kazim 70098907

Abdullah Tariq 70094397

Muhammad Usama 70095030

To be a leader in global healthcare, providing innovative medicines, vaccines, and consumer

 Maintain Financial Performance: Sustain a strong financial performance to support

 Promote Sustainability: Minimize our environmental impact through sustainable

PDCA Cycle (Plan-Do-Check-Act)

You might also like